Since analysis for the primary efficacy endpoint conducted in December 2015 showed a trend towards statistical difference between patients with SIBO and patients without SIBO, it was allowed for the study to enroll patients for another 6 months.
← all excerpts
Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth.
1
—
—